Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2026-07-02 17:15:43 ET · period of report 2026-07-01 · accession 0001601830-26-000091 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 17:15 | 2026-07-01 | RXRX | Li Dean Y | Dir | A - Grant | $0.00 | +3,747 | 1.47M | +0.3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-07-01 | A | A | 3,747 | $0.00 | 1,473,329 | D | — | — | (F1) The shares were issued pursuant to the Issuer's Outside Director Compensation Policy. |